VAERS reports by lot

GSK Varicella/Shingles lot 49ST9: VAERS reports

45 VAERS reports list lot 49ST9 as a GSK Varicella/Shingles vaccine, received between 2018-03-19 and 2019-06-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
9%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5227%
General / Systemic (non-local)4523%
Musculoskeletal2412%
Gastrointestinal189%
Dermatological (non-injection-site)168%
Neurological147%
Cardiac / Cardiovascular84%
Allergic / Anaphylactic53%
Respiratory53%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas8
California4
Illinois3
Colorado3
Virginia3
Minnesota2
Georgia2
Wisconsin2
Washington2
Kansas1
North Dakota1
Iowa1

Reports by month received

2018-033
2018-0416
2018-0513
2018-064
2018-073
2018-083
2018-101
2018-111
2019-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.